Amgen (AMGN)

R&D Expenses

$1.87B

Quarterly · Period ending: · USD

AMGN logo

AMGN R&D Expenses

Latest reported$1.87B
AMGN Quarterly R&D Expenses ($0.00 → $1.87B)
High-resolution chart · PNG

AMGN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
208,800,000
206,700,000
249,500,000
202,900,000
202,800,000
189,800,000
242,300,000
198,400,000
194,100,000
188,000,000
192,400,000
166,000,000
152,400,000
152,500,000
165,100,000
172,600,000
145,400,000
147,700,000
143,700,000
130,400,000
123,600,000
130,600,000
124,000,000
105,500,000
108,400,000
113,900,000
88,000,000
81,600,000
80,200,000
73,700,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.